Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00347750 |
Recruitment Status
:
Withdrawn
(lack of participants)
First Posted
: July 4, 2006
Last Update Posted
: November 3, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
HIV Infection AIDS | Drug: Lopinavir pharmacokinetic/pharmacodynamic analysis |
Study Type : | Observational |
Actual Enrollment : | 0 participants |
Time Perspective: | Prospective |
Official Title: | Pharmacokinetics and Pharmacodynamics of Lopinavir an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations |
Study Start Date : | September 2006 |
Actual Primary Completion Date : | September 2007 |
Actual Study Completion Date : | September 2007 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All HIV infected Ethiopian and Non-Ethiopian subjects
- AIDS diseased Ethiopian and Non-Ethiopian individuals
Exclusion Criteria:
- Individuals who are unable to sign the informed concent
- Individuals unable to take oral medications
- Individuals who described Lopinavir allergy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347750
Israel | |
Rambam Health Care Campus | |
Haifa, Israel, 31096 |
Principal Investigator: | Norberto Krivoy, MD | Rambam Health Care Campus |
ClinicalTrials.gov Identifier: | NCT00347750 History of Changes |
Other Study ID Numbers: |
001-2006.CTIL |
First Posted: | July 4, 2006 Key Record Dates |
Last Update Posted: | November 3, 2015 |
Last Verified: | April 2007 |
Keywords provided by Rambam Health Care Campus:
Lopinavir Pharmacokinetic Pharmacodynamic Ethiopian population Caucasian population |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Lopinavir |
Anti-HIV Agents HIV Protease Inhibitors Protease Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Anti-Retroviral Agents Antiviral Agents Anti-Infective Agents Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 Enzyme Inhibitors |